Related Experiment Video
Updated: Oct 18, 2025

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
A novel inactivated whole-cell Pseudomonas aeruginosa vaccine that acts through the cGAS-STING pathway
Cuicui Ma1, Xiao Ma2, Boguang Jiang1
1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy, Chengdu, 610041, China.
Abstract:
Pseudomonas aeruginosa infection continues to be a major threat to global public health, and new safe and efficacious vaccines are needed for prevention of infections caused by P. aeruginosa. X-ray irradiation has been used to prepare whole-cell inactivated vaccines against P. aeruginosa infection. However, the immunological mechanisms of X-ray-inactivated vaccines are still unclear and require further investigation. Our previous study found that an X-ray-inactivated whole-cell vaccine could provide protection against P. aeruginosa by boosting T cells. The aim of the present study was to further explore the immunological mechanisms of the vaccine. Herein, P. aeruginosa PAO1, a widely used laboratory strain, was utilized to prepare the vaccine, and we found nucleic acids and 8-hydroxyguanosine in the supernatant of X-ray-inactivated PAO1 (XPa). By detecting CD86, CD80, and MHCII expression, we found that XPa fostered dentritic cell (DC) maturation by detecting. XPa stimulated the cGAS-STING pathway as well as Toll-like receptors in DCs in vitro, and DC finally underwent apoptosis and pyroptosis after XPa stimulation. In addition, DC stimulated by XPa induced CD8+ T-cell proliferation in vitro and generated immunologic memory in vivo. Moreover, XPa vaccination induced both Th1 and Th2 cytokine responses in mice and reduced the level of inflammatory factors during infection. XPa protected mice in pneumonia models from infection with PAO1 or multidrug-resistant clinical isolate W9. Chronic obstructive pulmonary disease (COPD) mice immunized with XPa could resist PAO1 infection. Therefore, a new mechanism of an X-ray-inactivated whole-cell vaccine against P. aeruginosa infection was discovered in this study.
Insights
This study reveals how X-ray inactivated Pseudomonas aeruginosa (XPa) vaccines activate dendritic cells (DCs) and T cells, offering protection against P. aeruginosa infections, including in COPD models.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- Pseudomonas aeruginosa infections pose a significant global health threat, necessitating novel vaccines.
- Current understanding of X-ray inactivated whole-cell vaccines' immunological mechanisms against P. aeruginosa is limited.
- Previous research indicated T cell boosting by X-ray inactivated P. aeruginosa vaccines.
Purpose of the Study:
- To elucidate the immunological mechanisms underlying the efficacy of X-ray inactivated P. aeruginosa (XPa) whole-cell vaccines.
- To investigate the interaction of XPa with dendritic cells (DCs) and its impact on immune cell activation.
- To evaluate the protective potential of XPa against P. aeruginosa infections in various mouse models.
Main Methods:
- Preparation of XPa vaccine from P. aeruginosa PAO1.
- Assessment of XPa's effects on DC maturation markers (CD86, CD80, MHCII) and pathways (cGAS-STING, Toll-like receptors).
- Evaluation of XPa-induced T cell proliferation, immunologic memory, cytokine responses, and protection in pneumonia and COPD mouse models.
Main Results:
- XPa contains nucleic acids and 8-hydroxyguanosine.
- XPa promotes DC maturation, apoptosis, and pyroptosis via cGAS-STING and Toll-like receptor pathways.
- XPa stimulates CD8+ T cell proliferation, induces immunologic memory, and elicits Th1/Th2 cytokine responses.
- XPa vaccination reduces inflammatory factors and protects mice against P. aeruginosa PAO1 and multidrug-resistant W9 infections, including in COPD models.
Conclusions:
- XPa vaccination elicits a protective immune response against P. aeruginosa by modulating DC function and T cell activation.
- The study uncovers a novel mechanism for X-ray inactivated whole-cell vaccines against P. aeruginosa.
- XPa demonstrates potential as a safe and effective vaccine candidate for preventing P. aeruginosa infections, even in vulnerable populations like COPD patients.
More Related Videos
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
GPCRs Regulate Adenylyl Cylase Activity
Gene Regulation in Microbial Communities: Quorum Sensing

